SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of
plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in …

As is often the case, one cannot give a simple answer to the question: plasmapheresis-take
it or leave it? A thorough review of the current data on the possible mechanisms of action …

Plasmapheresis has been performed in eleven cases with connective tissue diseases, three
with systemic lupus erythematosus, three with mixed connective tissue disease and five with …

Fourteen patients with active systemic lupus erythematosus (SLE) have been treated with
plasmapheresis at a rate of two litres daily on three to four days per week, over a period of …

The effectivity of a combination of various plasma exchange regimens in combination with
immunosuppressive medication consisting of corticosteroids and cyclophosphamide was …

Twenty-six patients with rheumatoid arthritis (average age, 57 years; average duration of
disease, 11 years) who were unresponsive to antiinflammatory and slow-acting …

Plasmapheresis was used as the sole treatment modality in 4 patients with systemic lupus
erythematosus. The presence of circulating immune complexes in this group of patients was …

Standard treatment for severe systemic lupus erythematosus (SLE) consists of
corticosteroids and immunosuppressive drugs. A number of controlled studies purport to …

Extensive immunologic evaluation was made of a patient with severe systemic lupus
erythematosus (SLE) undergoing 6 cycles of plasmapheresis combined with pulsed …

The rarity with which therapy-free remission is achieved in patients with severe SLE demand
the continued search for improved treatment strategies. Possibly, therapeutic results can be …